Compare UIS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UIS | PROF |
|---|---|---|
| Founded | 1942 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.2M | 247.5M |
| IPO Year | 1994 | 2017 |
| Metric | UIS | PROF |
|---|---|---|
| Price | $4.06 | $7.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.67 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 903.3K | 71.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.89 |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $1,950,100,000.00 | $16,098,000.00 |
| Revenue This Year | N/A | $92.40 |
| Revenue Next Year | $2.60 | $64.10 |
| P/E Ratio | ★ N/A | $38.58 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $1.97 | $3.92 |
| 52 Week High | $4.98 | $8.95 |
| Indicator | UIS | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 62.11 | 54.80 |
| Support Level | $3.44 | $7.00 |
| Resistance Level | $4.98 | $7.94 |
| Average True Range (ATR) | 0.24 | 0.36 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 79.37 | 49.21 |
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.